Prognostic biomarker validation in high grade serous carcinoma with the ovarian tumor tissue analysis consortium and the multidisciplinary ovarian cancer outcomes group Article
Full Text via DOI: 10.1016/j.ygyno.2024.07.638
Web of Science: 001330731400631

